141 related articles for article (PubMed ID: 31207262)
1. Perfusion cell culture for the production of conjugated recombinant fusion proteins reduces clipping and quality heterogeneity compared to batch-mode processes.
Bielser JM; Chappuis L; Xiao Y; Souquet J; Broly H; Morbidelli M
J Biotechnol; 2019 Aug; 302():26-31. PubMed ID: 31207262
[TBL] [Abstract][Full Text] [Related]
2. Bioreactor productivity and media cost comparison for different intensified cell culture processes.
Xu S; Gavin J; Jiang R; Chen H
Biotechnol Prog; 2017 Jul; 33(4):867-878. PubMed ID: 27977910
[TBL] [Abstract][Full Text] [Related]
3. Perfusion CHO cell culture applied to lower aggregation and increase volumetric productivity for a bispecific recombinant protein.
Gomez N; Barkhordarian H; Lull J; Huh J; GhattyVenkataKrishna P; Zhang X
J Biotechnol; 2019 Oct; 304():70-77. PubMed ID: 31381940
[TBL] [Abstract][Full Text] [Related]
4. Developing an ultra-intensified fed-batch cell culture process with greatly improved performance and productivity.
Xiang S; Zhang J; Yu L; Tian J; Tang W; Tang H; Xu K; Wang X; Cui Y; Ren K; Cao W; Su Y; Zhou W
Biotechnol Bioeng; 2024 Feb; 121(2):696-709. PubMed ID: 37994547
[TBL] [Abstract][Full Text] [Related]
5. Improving product quality and productivity of bispecific molecules through the application of continuous perfusion principles.
Gomez N; Lull J; Yang X; Wang Y; Zhang X; Wieczorek A; Harrahy J; Pritchard M; Cano DM; Shearer M; Goudar C
Biotechnol Prog; 2020 Jul; 36(4):e2973. PubMed ID: 31991523
[TBL] [Abstract][Full Text] [Related]
6. Concentrated fed-batch cell culture increases manufacturing capacity without additional volumetric capacity.
Yang WC; Minkler DF; Kshirsagar R; Ryll T; Huang YM
J Biotechnol; 2016 Jan; 217():1-11. PubMed ID: 26521697
[TBL] [Abstract][Full Text] [Related]
7. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.
Yang WC; Lu J; Kwiatkowski C; Yuan H; Kshirsagar R; Ryll T; Huang YM
Biotechnol Prog; 2014; 30(3):616-25. PubMed ID: 24574326
[TBL] [Abstract][Full Text] [Related]
8. Perfusion Cell Culture Decreases Process and Product Heterogeneity in a Head-to-Head Comparison With Fed-Batch.
Walther J; Lu J; Hollenbach M; Yu M; Hwang C; McLarty J; Brower K
Biotechnol J; 2019 Feb; 14(2):e1700733. PubMed ID: 29851298
[TBL] [Abstract][Full Text] [Related]
9. A novel scale-down mimic of perfusion cell culture using sedimentation in an automated microbioreactor (SAM).
Kreye S; Stahn R; Nawrath K; Goralczyk V; Zoro B; Goletz S
Biotechnol Prog; 2019 Sep; 35(5):e2832. PubMed ID: 31050211
[TBL] [Abstract][Full Text] [Related]
10. Process intensification to produce a difficult-to-express therapeutic enzyme by high cell density perfusion or enhanced fed-batch.
Särnlund S; Jiang Y; Chotteau V
Biotechnol Bioeng; 2021 Sep; 118(9):3533-3544. PubMed ID: 33914903
[TBL] [Abstract][Full Text] [Related]
11. Cell culture process operations for recombinant protein production.
Abu-Absi S; Xu S; Graham H; Dalal N; Boyer M; Dave K
Adv Biochem Eng Biotechnol; 2014; 139():35-68. PubMed ID: 24153406
[TBL] [Abstract][Full Text] [Related]
12. Perfusion mammalian cell culture for recombinant protein manufacturing - A critical review.
Bielser JM; Wolf M; Souquet J; Broly H; Morbidelli M
Biotechnol Adv; 2018; 36(4):1328-1340. PubMed ID: 29738813
[TBL] [Abstract][Full Text] [Related]
13. Pre-stage perfusion and ultra-high seeding cell density in CHO fed-batch culture: a case study for process intensification guided by systems biotechnology.
Stepper L; Filser FA; Fischer S; Schaub J; Gorr I; Voges R
Bioprocess Biosyst Eng; 2020 Aug; 43(8):1431-1443. PubMed ID: 32266469
[TBL] [Abstract][Full Text] [Related]
14. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
15. The effect of hyperosmolality application time on production, quality, and biopotency of monoclonal antibodies produced in CHO cell fed-batch and perfusion cultures.
Qin J; Wu X; Xia Z; Huang Z; Zhang Y; Wang Y; Fu Q; Zheng C
Appl Microbiol Biotechnol; 2019 Feb; 103(3):1217-1229. PubMed ID: 30554388
[TBL] [Abstract][Full Text] [Related]
16. Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty.
Pollock J; Ho SV; Farid SS
Biotechnol Bioeng; 2013 Jan; 110(1):206-19. PubMed ID: 22806692
[TBL] [Abstract][Full Text] [Related]
17. Cell-controlled hybrid perfusion fed-batch CHO cell process provides significant productivity improvement over conventional fed-batch cultures.
Hiller GW; Ovalle AM; Gagnon MP; Curran ML; Wang W
Biotechnol Bioeng; 2017 Jul; 114(7):1438-1447. PubMed ID: 28128436
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for Comparison of Productivity Between Fed-Batch and Perfusion Processes.
Bausch M; Schultheiss C; Sieck JB
Biotechnol J; 2019 Feb; 14(2):e1700721. PubMed ID: 30024096
[TBL] [Abstract][Full Text] [Related]
19. Process intensification for the production of rituximab by an inducible CHO cell line.
Mellahi K; Brochu D; Gilbert M; Perrier M; Ansorge S; Durocher Y; Henry O
Bioprocess Biosyst Eng; 2019 May; 42(5):711-725. PubMed ID: 30673843
[TBL] [Abstract][Full Text] [Related]
20. High cell density fed batch and perfusion processes for stable non-viral expression of secreted alkaline phosphatase (SEAP) using insect cells: comparison to a batch Sf-9-BEV system.
Jardin BA; Montes J; Lanthier S; Tran R; Elias C
Biotechnol Bioeng; 2007 Jun; 97(2):332-45. PubMed ID: 17054119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
